StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)

Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%

Conmed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Conmed's total debt was $815.87M at Sep 30, 2026. For fiscal 2025 it was $834.94M, down 7.8% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $1.05B in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$834.94M-7.8%
FY2024Dec 31, 2024$905.78M-7.0%
FY2023Dec 31, 2023$973.85M-7.7%
FY2022Dec 31, 2022$1.05B+54.1%
FY2021Dec 31, 2021$684.66M-9.2%
FY2020Dec 31, 2020$753.64M-2.0%
FY2019Dec 31, 2019$768.81M+68.3%
FY2018Dec 31, 2018$456.90M-6.1%
FY2017Dec 31, 2017$486.44M-2.4%
FY2016Dec 31, 2016$498.49M+84.1%
FY2015Dec 31, 2015$270.81M+12.2%
FY2014Dec 31, 2014$241.44M+12.0%
FY2013Dec 31, 2013$215.58M+33.2%
FY2012Dec 31, 2012$161.85M+12.8%
FY2011Dec 31, 2011$143.51M-26.6%
FY2010Dec 31, 2010$195.62M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$815.87M-4.4%
Q2 FY2026Jun 30, 2026$834.25M-5.4%
Q1 FY2026Mar 31, 2026$860.87M-3.5%
Q4 FY2025Dec 31, 2025$834.94M-7.8%
Q3 FY2025Sep 30, 2025$853.75M-9.3%
Q2 FY2025Jun 30, 2025$881.83M-8.7%
Q1 FY2025Mar 31, 2025$892.16M-10.0%
Q4 FY2024Dec 31, 2024$905.78M-7.0%
Q3 FY2024Sep 30, 2024$940.81M-7.1%
Q2 FY2024Jun 30, 2024$965.89M-7.2%
Q1 FY2024Mar 31, 2024$990.80M-7.0%
Q4 FY2023Dec 31, 2023$973.85M-7.7%
Q3 FY2023Sep 30, 2023$1.01B-2.3%
Q2 FY2023Jun 30, 2023$1.04B+5.9%
Q1 FY2023Mar 31, 2023$1.06B+48.8%
Q4 FY2022Dec 31, 2022$1.05B+54.1%
Q3 FY2022Sep 30, 2022$1.04B+44.9%
Q2 FY2022Jun 30, 2022$982.70M+34.7%
Q1 FY2022Mar 31, 2022$715.77M-4.0%
Q4 FY2021Dec 31, 2021$684.66M-9.2%
Q3 FY2021Sep 30, 2021$715.59M-7.9%
Q2 FY2021Jun 30, 2021$729.68M-9.4%
Q1 FY2021Mar 31, 2021$745.40M-5.2%
Q4 FY2020Dec 31, 2020$753.64M-2.0%
Q3 FY2020Sep 30, 2020$777.26M-2.1%
Q2 FY2020Jun 30, 2020$805.62M-0.5%
Q1 FY2020Mar 31, 2020$786.20M-3.9%
Q4 FY2019Dec 31, 2019$768.81M+68.3%
Q3 FY2019Sep 30, 2019$794.17M+72.3%
Q2 FY2019Jun 30, 2019$809.66M+80.3%
Q1 FY2019Mar 31, 2019$817.94M+78.5%
Q4 FY2018Dec 31, 2018$456.90M-6.1%
Q3 FY2018Sep 30, 2018$460.95M-9.3%
Q2 FY2018Jun 30, 2018$449.19M-9.5%
Q1 FY2018Mar 31, 2018$458.20M-8.1%
Q4 FY2017Dec 31, 2017$486.44M-2.4%
Q3 FY2017Sep 30, 2017$508.33M–
Q2 FY2017Jun 30, 2017$496.48M–
Q1 FY2017Mar 31, 2017$498.34M–
Q4 FY2016Dec 31, 2016$498.49M–

More Conmed figures

See a number that looks wrong?